Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé foci, Mali

Basáñez, M-G; Walker, M; Nutman, T B; Colebunders, R; Diarra, D; Coulibaly, M E; Soumaoro, L; Diallo, A A; Dicko, I; Sangare, M B; Coulibaly, S Y; Doumbia, S S; Dembélé, M; Sow, M; Coulibaly, Y I; Dolo, H

Abstract

In Mali, ivermectin-based onchocerciasis elimination from the Bakoye and Falémé foci, reported in 2009–2012, was a beacon leading to policy shifting from morbidity control to elimination of transmission (EOT). These foci are also endemic for lymphatic filariasis (LF). In 2007–2016 mass ivermectin plus albendazole administration was implemented. We report Ov16 (onchocerciasis) and Wb123 (LF) seroprevalence after 24–25 years of treatment to evaluate if onchocerciasis EOT and LF elimination as a public health problem (EPHP) have been achieved.

Citation

Basáñez, M., Walker, M., Nutman, T. B., Colebunders, R., Diarra, D., Coulibaly, M. E., …Dolo, H. (2020). Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé foci, Mali. Clinical Infectious Diseases, https://doi.org/10.1093/cid/ciaa318

• Journal Article Type: Article
• Acceptance Date: Mar 12, 2020
• Publication Date: Mar 24, 2020
• Deposit Date: Apr 1, 2020
• Publicly Available Date: Apr 1, 2020
• Journal: Clinical Infectious Diseases
• Print ISSN: 1058-4838
• Publisher: Oxford University Press
• Peer Reviewed: Peer Reviewed
• DOI: https://doi.org/10.1093/cid/ciaa318
• Public URL: https://rvc-repository.worktribe.com/output/1377943